Stay updated on BJ-001 IL-15 Fusion Protein Safety Clinical Trial
Sign up to get notified when there's something new on the BJ-001 IL-15 Fusion Protein Safety Clinical Trial page.

Latest updates to the BJ-001 IL-15 Fusion Protein Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record now includes a Recruitment Status entry, updating the Study Status and associated contacts/locations.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check36 days agoChange Detected- The page has updated its operating status and revision version; the new content adds a government-funding notice and current operating status guidance, while older status and revision (Active, not recruiting; v3.1.0) were removed. Overall, the page now communicates current status and a newer version (v3.2.0) with an updated notice about potential delays in responses due to appropriations. If you are using this for user-facing information, the new iteration emphasizes current operating status and a higher revision number.SummaryDifference15%

- Check44 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check58 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No other substantive changes to core content, pricing, stock, or timing.SummaryDifference0.7%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.7%

- Check72 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference13%

Stay in the know with updates to BJ-001 IL-15 Fusion Protein Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BJ-001 IL-15 Fusion Protein Safety Clinical Trial page.